These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10343182)

  • 1. Lithium and haloperidol treatments differently affect the mononuclear leukocyte Galphas protein levels in bipolar affective disorder.
    Karege F; Golaz J; Schwald M; Malafosse A
    Neuropsychobiology; 1999 May; 39(4):181-6. PubMed ID: 10343182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of Galphas mRNA and protein levels in lithium-treated bipolar affective disorder.
    Karege F; Buresi C; Golaz J; Schwald M; Malafosse A
    Hum Psychopharmacol; 2000 Apr; 15(3):191-197. PubMed ID: 12404332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of the combination of lithium and neuroleptic drugs.
    Goldney RD; Spence ND
    Am J Psychiatry; 1986 Jul; 143(7):882-4. PubMed ID: 2872825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder.
    Kikuchi K; Iga J; Tayoshi S; Nakataki M; Watanabe S; Numata S; Ohmori T
    Hum Psychopharmacol; 2011; 26(4-5):358-63. PubMed ID: 21721043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
    Normann C; Brandt C; Berger M; Walden J
    Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased inositol-monophosphatase activity by lithium treatment in bipolar patients.
    Kaya N; Resmi H; Ozerdem A; Guner G; Tunca Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):521-7. PubMed ID: 15093960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroencephalographic changes and other indices of neurotoxicity with haloperidol-lithium therapy.
    Saran A; Addy O; Foliart RH; Schubert DS; Halaris A
    Neuropsychobiology; 1989; 20(3):152-7. PubMed ID: 2569693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment.
    Isgren A; Jakobsson J; Pålsson E; Ekman CJ; Johansson AG; Sellgren C; Blennow K; Zetterberg H; Landén M
    Brain Behav Immun; 2015 Jan; 43():198-204. PubMed ID: 25451615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions in treatment with lithium carbonate and haloperidol.
    Baastrup PC; Hollnagel P; Sorensen R; Schou M
    JAMA; 1976 Dec; 236(23):2645-6. PubMed ID: 1036539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan depletion in recently manic patients treated with lithium.
    Cassidy F; Murry E; Carroll BJ
    Biol Psychiatry; 1998 Feb; 43(3):230-2. PubMed ID: 9494705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania.
    Chan HY; Jou SH; Juang YY; Chang CJ; Chen JJ; Chen CH; Chiu NY
    Psychiatry Clin Neurosci; 2010 Apr; 64(2):162-9. PubMed ID: 20447012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania.
    Garfinkel PE; Stancer HC; Persad E
    J Affect Disord; 1980 Dec; 2(4):279-88. PubMed ID: 6450787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium might be associated with better decision-making performance in euthymic bipolar patients.
    Adida M; Jollant F; Clark L; Guillaume S; Goodwin GM; Azorin JM; Courtet P
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):788-97. PubMed ID: 25840740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC; Hsu MC; Yeh IN; Kuo CC
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol.
    Shopsin B; Gershon S; Thompson H; Collins P
    Arch Gen Psychiatry; 1975 Jan; 32(1):34-42. PubMed ID: 1089401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New data on lithium and haloperidol incompatibility.
    Spring G; Frankel M
    Am J Psychiatry; 1981 Jun; 138(6):818-21. PubMed ID: 6113770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antipsychotic drugs and lithium in mania.
    Cookson J
    Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.